We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current APLT market cap is 453.2M. The company's latest EPS is USD -1.1310 and P/E is -3.79.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 10.66M | 0 | 0 |
| Operating Income | -19.36M | -18.97M | -10.86M | -17.18M | -15.49M |
| Net Income | -19.1M | -14.43M | -10.14M | -29.58M | -42.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 9.99M |
| Operating Income | -45.58M | -94.47M | -105.62M | -82.95M | -64.54M |
| Net Income | -45.51M | -93.96M | -105.58M | -82.51M | -119.76M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 56.68M | 38.36M | 30M | 43.65M | 45.2M |
| Total Liabilities | 47.05M | 34.3M | 34.08M | 47.98M | 56.24M |
| Total Equity | 9.63M | 4.06M | -4.07M | -4.33M | -11.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 48.39M | 104.51M | 89.89M | 38.36M | 54.83M |
| Total Liabilities | 15.78M | 22.57M | 27.35M | 34.3M | 71.98M |
| Total Equity | 32.61M | 81.94M | 62.54M | 4.06M | -17.15M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -62.2M | -78.09M | -6.99M | -23.44M | -38.17M |
| Investing | 20.08M | 13.17M | 13.87M | 13.87M | 13.87M |
| Financing | 28.63M | 27.69M | -622k | 28.53M | 45.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -36.31M | -78.21M | -90.73M | -78.09M | -55.17M |
| Investing | -20.01M | -19.47M | 12.43M | 13.17M | 13.87M |
| Financing | 56.42M | 136.29M | 74.72M | 27.69M | 74.54M |
| Market Cap | 453.2M |
| Price to Earnings Ratio | -3.79 |
| Price to Sales Ratio | 45.44 |
| Price to Cash Ratio | 9.1 |
| Price to Book Ratio | -26.49 |
| Dividend Yield | - |
| Shares Outstanding | 105.89M |
| Average Volume (1 week) | 1.15M |
| Average Volume (1 Month) | 964.16k |
| 52 Week Change | 214.71% |
| 52 Week High | 9.39 |
| 52 Week Low | 1.18 |
| Spread (Intraday) | 7.05 (62.95%) |
| Company Name | Applied Therapeutics Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.appliedtherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
